CN Patent

CN105801481A — 一种乐伐替尼的合成方法

Assigned to HUNAN OUYA BIOLOGICAL CO Ltd · Expires 2016-07-27 · 10y expired

What this patent protects

本发明公开了一种乐伐替尼的合成方法。该方法将4‑氨基‑3‑氯苯酚与氯甲酸苄酯进行酰胺化反应;将得到的4‑(苄氧羰基)氨基‑3‑氯苯酚与4‑氯‑7‑甲氧基喹啉‑6‑甲酰胺进行缩合反应;将得到的4‑[3‑氯‑4‑(苄氧羰基)氨基苯氧基]‑7‑甲氧基喹啉‑6‑甲酰胺与环丙胺进行酰胺化反应,得到成品乐伐替尼。该方法的工艺路线步骤较短,操作简化,成本较低,是一种绿色环保方法,适用于工业化生产。

USPTO Abstract

本发明公开了一种乐伐替尼的合成方法。该方法将4‑氨基‑3‑氯苯酚与氯甲酸苄酯进行酰胺化反应;将得到的4‑(苄氧羰基)氨基‑3‑氯苯酚与4‑氯‑7‑甲氧基喹啉‑6‑甲酰胺进行缩合反应;将得到的4‑[3‑氯‑4‑(苄氧羰基)氨基苯氧基]‑7‑甲氧基喹啉‑6‑甲酰胺与环丙胺进行酰胺化反应,得到成品乐伐替尼。该方法的工艺路线步骤较短,操作简化,成本较低,是一种绿色环保方法,适用于工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN105801481A
Jurisdiction
CN
Classification
Expires
2016-07-27
Drug substance claim
No
Drug product claim
No
Assignee
HUNAN OUYA BIOLOGICAL CO Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.